| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |